Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer

Androgen receptor (AR) signaling remains the key therapeutic target in the management of hormone‐naïve‐advanced prostate cancer (PCa) and castration‐resistant PCa (CRPC). Recently, landmark molecular features have been reported for CRPC, including the expression of constitutively active AR variants...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdmann, Éva, Ould Madi Berthélémy, Pauline, Cottard, Félicie, Angel, Charlotte Zoe, Schreyer, Edwige, Ye, Tao, Morlet, Bastien, Negroni, Luc, Kieffer, Bruno, Céraline, Jocelyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462842/
https://www.ncbi.nlm.nih.gov/pubmed/34919781
http://dx.doi.org/10.1002/1878-0261.13164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462842/
https://www.ncbi.nlm.nih.gov/pubmed/34919781
http://dx.doi.org/10.1002/1878-0261.13164

Ejemplares similares